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Chapter
IntroductIon & outlIne 
of the thesIs1
Begin at the beginning and go on till you come to the end: then stop.





The blood is one of the most intensely studied and best understood human 
tissues. It performs many functions in the body and consists of red blood cells, 
white blood cells and platelets suspended in plasma. Red blood cells (also referred 
to as erythrocytes) are the most common type of blood cell and carry oxygen to 
the body tissues. White blood cells are much less numerous than red blood cells. 
Their function is to protect the body from infection. White blood cells consist 
of myeloid and lymphoid cells. The myeloid cell compartment is made up of 
granulocytes (neutrophils, basophils, eosinophils) and monocytes/macrophages 
that collectively combat infections from bacteria, fungi, and other parasites such 
as worms. Some of these cells also have the ability to remove dead or damaged 
tissues. The lymphoid cell compartment is made up of B- and T-lymphocytes. 
B-lymphocytes produce antibodies that bind to antigens, while T-lymphocytes 
can directly attack and destroy cells recognized as foreign to the body, including 
virus-infected cells and cancer cells. Platelets (also referred to as thrombocytes) 
are derived from fragmentation of megakaryocytes and play an essential role in 
the blood clotting process.
Many blood cells are short-lived and therefore must be constantly replenished. 
A healthy human adult requires billions of new blood cells on a daily basis. 
The process by which these cells are produced is called hematopoiesis and is 
maintained by a small population of hematopoietic stem cells (HSCs).
Hallmark Properties of HSCs
The hematopoietic system is hierarchically organized with HSCs at the top of 
the pyramid and mature blood cells at the bottom of the pyramid. HSCs have 
two core properties, the combination of which makes them unique. First, they 
have long-term self-renewal potential, meaning that they can make identical 
copies of themselves for long periods of time. Second, they have multi-lineage 
differentiation potential, meaning that they can differentiate into the many 
specialized cell types that make up the blood system. HSCs generate intermediate 
cell types or progenitors that proliferate and become progressively more restricted 
in developmental potential, until ultimately mature blood cells are formed 
(Figure 1). Careful control of the balance between HSC self-renewal and 
differentiation is essential to maintain blood cell homeostasis. In a homeostatic 
system, the HSC self-renewal probability P is 0.5, indicating that on average half 
of the progeny of the HSCs preserves stem cell characteristics, whereas the other 
half initiates differentiation. If self-renewal of HSCs is impaired (P<0.5) the stem 
cell pool will exhaust, ultimately resulting in bone marrow failure. In contrast, if 
self-renewal of HSCs is increased (P>0.5) the stem cell pool will expand, ultimately 
resulting in blood cancer.1 
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HSCs are forced to constantly make fate decisions; they may remain quiescent, 
undergo apoptosis or initiate cell division. Once the decision to divide has 
been made, they must choose whether to self-renew or to differentiate into a 
specific blood cell type. HSC fate decisions are controlled by a complex interplay 
between cell-autonomous (intrinsic) and cell-nonautonomous (extrinsic) signals. 
Yet, the exact mechanisms governing these decisions are still poorly understood. 
The continued quest for these mechanisms will not only be of major relevance 
for a fundamental understanding of normal hematopoiesis and developmental 
biology, but also for a better understanding of the pathogenesis and evolution 
of blood cancers. In addition, it will open new avenues for the design of ex vivo 
expansion protocols for HSCs, thereby increasing their clinical potential in cell 
replacement and gene therapy protocols. The delineation of the mechanisms 



























Figure 1. Hierarchical organization of the blood system. Hematopoietic stem cells (HSCs) 
give rise to more committed progenitors that in turn produce the different blood cell types.
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Phenotypic Characterization of HSCs
Characterizing HSCs began by studies in rodents, which laid the foundation for 
studies in humans. The major challenge in HSC studies is that the stem cells 
themselves are rare, representing less than 0.01% of the cells within the bone 
marrow, and that the stem cells cannot be identified based on their morphology 
(size and shape), but solely based on their immunophenotype. The general 
consensus is that mouse HSCs lack the cell surface markers that are expressed 
on differentiated hematopoietic cells (so-called lineage or lin markers), but do 
express “stem cell antigen-1” (Sca-1) and c-Kit (collectively referred to as LSK).2;3 
The cells in this LSK population can be further subfractionated into long-term (LT) 
and short-term (ST) HSCs (both containing self-renewal capacity) and progenitors 
(containing low/no self-renewal capacity). LT-HSCs can be more precisely identified 
within the LSK population by selecting for those cells that are CD34−,4 Flk-2/
Flt3−,5;6 CD48− and CD150+,7 EPCR/CD201+,8 and different combinations thereof. 
Another approach to identify HSCs relies on their ability to efflux vital dyes such 
as Hoechst 333429 and Rhodamine 123.10-13 The prospective isolation of mouse 
HSCs by fluorescence-activated cell sorting (FACS) has facilitated the functional 
and molecular characterization of HSCs.
Functional Characterization of HSCs
HSC studies depend on several in vitro and in vivo assays to measure the quantity 
and/or quality of hematopoietic stem and progenitor cells. Several in vitro assays 
have been established that can measure the frequency of progenitors (colony-
forming unit in culture; CFU-C), stem cells (long-term culture-initiating cell; 
LTC-IC) or both (cobblestone-area forming cell assay; CAFC).14;15 At present, the 
ultimate model used to demonstrate HSC activity is in vivo transplantation; the 
only assay that can measure both the long-term self-renewal and multi-lineage 
differentiation capacity of HSCs.16;17 In this assay, HSCs are transplanted into 
myeloablated (usually irradiated) recipients after which their ability to produce 
multi-lineage progeny for prolonged periods of time is evaluated. It should be 
realized, however, that in all the above-mentioned assays HSCs are measured 
retrospectively. By the time HSC activity is established, the original HSC will 
unavoidably be lost. 
The existence of true HSCs with long-term self-renewal activity and multi-lineage 
differentiation capacity has been irrefutably demonstrated by retroviral marking 
studies,18;19 limiting dilution20-22 and single purified cell assays.23-26 However, thus 
far it has remained difficult to quantify the exact number of HSCs that actively 
contribute to hematopoiesis or to simultaneously analyze the behavior of multiple 
individual HSCs in a competitive polyclonal setting. That type of analysis could 
help resolve some of the major outstanding questions in HSC biology, such as 
whether lineage-biased and dormant or hibernating HSCs really do exist,27-30 and 
how clonal relationships in the hematopoietic system are established. 
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Molecular Characterization of HSCs
Systems Biology
State-of-the-art genome-wide tools have become available to elucidate the 
intrinsic properties of HSCs. To identify genes that play a key role in regulating 
HSC fate decisions, several groups have embarked on genome-wide mRNA 
expression studies. In an attempt to identify a HSC molecular signature, the 
expression profiles of HSCs, embryonic stem cells and neural stem cells have 
been compared.31;32 Furthermore, mRNA profiles have been analyzed in HSCs 
from young versus old animals,33;34 in quiescent versus proliferating HSCs,35 and 
in HSCs versus their differentiated progeny.36-39 However, to explain complex 
biological phenomena it is not enough to study mRNA expression alone; it is of 
vital importance to measure – in the same sample – complementary biological 
variables. Only then HSCs can be studied from a systems perspective. 
More recently, novel genome-wide tools have been developed to study 
alternative splicing, microRNA expression, protein expression and post-
translational modifications, transcription factor and cofactor binding sites, 
epigenetic marks such as histone modifications and DNA methylation, and 
chromatin accessibility. All these types of analyses thus far remain challenging in 
HSCs, because of the limiting cell numbers available per mouse. Yet, technology is 
rapidly evolving and may soon provide a hitherto unprecedented amount of data 
on HSCs. The challenge that therefore lies ahead is to integrate all these different 
types of data using various bioinformatics and systems biology approaches. The 
ultimate goal will be to construct regulatory networks that allow us to model, 
predict and potentially control HSC fate. 
Systems Genetics
Quantitative differences can be observed for most complex behavioral and 
physiological traits among individuals within any population. These differences 
can be due to both genetic and environmental factors. The mouse, with its long 
history of genetic research, has proven to be an excellent model to study the 
genetic basis for these quantitative differences. Specifically, the regular inbred 
mouse strains C57BL/6 (B6) and DBA/2 (D2) have been extensively studied. With 
respect to HSCs these strains differ for example in their pool size, proliferation 
rates, reconstitution kinetics, deterioration rate during aging and mobilization 
response.40-46 The underlying causes of variation in these quantitative traits must 
be encoded in the genomes of these mice. 
The use of the BXD recombinant inbred mouse panel has proven to be a 
useful strategy to pinpoint the genomic regions that could be responsible for the 
observed variation in HSC traits. This panel has been derived by crossing B6 and 
D2 mouse strains and then inbreeding progeny for many generations.47-49 As a 
result, the genomes of both parental strains have recombined and have become 
fixed (i.e. are homozygous) in a unique pattern in each of the BXD lines. The panel 
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of BXDs has been extensively genotyped and phenotyped. In order to identify 
the genomic regions that influence the above-mentioned HSC traits an approach 
called quantitative trait locus (QTL) mapping could be employed. This approach 
makes use of statistical methods that search for associations between variation in 
the phenotypic trait and possession of a particular allele. In this manner, genomic 
loci have been identified that influenced the pool size, proliferation rate and 
mobilization response of HSCs.50-55 
More recently, an approach called expression QTL (eQTL) mapping has been 
employed to delineate the genetic basis of gene expression. In this approach, 
variation in transcript abundance is considered to be a quantitative trait that can 
be mapped to genomic loci.56;57 This approach has been implemented by our 
laboratory on a genome-wide scale to study gene regulation in HSCs.58 Soon after, 
a combinatorial analysis of physiological QTLs and eQTLs led to the identification 
of Lxn as a gene involved in regulating HSC pool size,59 and EGFR signaling as a 
pathway involved in regulating HSC mobilization.60 Discoveries such as these have 
invigorated the field of HSC biology and have fuelled excitement to continue 
systems genetics studies on HSCs.
OUTLINE OF THE THESIS
The overall aim of the research described in this thesis is to improve our 
understanding of the mechanisms governing stem cell fate decisions and lineage 
commitment within the hematopoietic system. We try to achieve this goal by 
exploiting two types of genetic variation in the mouse: 
I) naturally occurring genetic variation (chapters 2-6) 
II) Induced genetic variation (chapter 7)
chapter 2 introduces the concepts of classical QTL mapping and expression 
QTL mapping. It reviews past studies in which transcriptional profiling and/or 
genetic linkage analysis were performed on hematopoietic cells, and serves as an 
introduction to chapters 3-6. 
chapter 3 describes an eQTL mapping study on four hematopoietic cell types 
isolated from a panel of BXD recombinant inbred mouse strains. Thus far, most 
eQTL mapping studies that have been reported have analyzed single cell types or 
compared developmentally unrelated and distant cell types. This chapter reports 
the first study of eQTL dynamics across closely related cell types during cellular 
development. It covers the identification of consistently active (or “static”) eQTLs 
and cell-type-dependent (or “dynamic”) eQTLs.
chapter 4 introduces a method that infers combinatorial association logic 
networks in multimodal genome-wide screens. Traditional eQTL mapping 
methods detect direct associations between genetic loci and transcript levels. 
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However, when the genetic loci themselves interact, direct associations between 
the individual loci and transcript levels may become undetectable. To alleviate 
this problem, the method described in this chapter detects associations between 
transcript levels and the outputs of small Boolean logic networks that combine 
multiple genetic loci. 
chapter 5 illustrates how the presence of genetic variation in a pedigree 
of normal, wild-type, mice can be exploited to (re)construct gene networks 
that operate in successive stages of cellular development. It starts with the 
reconstruction of an experimentally validated gene network, and proceeds with 
the construction of a novel gene network for transcripts that are specific to the 
HSC-enriched cell population. Finally, a combinatorial analysis of classical QTL 
and eQTL data leads to the identification of a zinc-finger transcription factor as a 
candidate regulator of the size of the HSC pool. 
chapter 6 describes a microRNA profiling study on four developmentally 
related hematopoietic cell types isolated from B6 and D2 mouse strains. It covers 
the identification of cell type-dependent and mouse strain-dependent microRNAs. 
Of special interest is an evolutionary conserved microRNA cluster that is most 
highly expressed in the HSC-enriched cell population and that is differentially 
expressed between mouse strains. To assess whether the differential expression of 
this cluster could be functional, we overexpressed it beyond its normal expression 
level, and found that this fixed hematopoietic cells in a primitive state. Finally, we 
identify the downstream mRNA targets through which this microRNA cluster may 
exert its effect.
chapter 7 introduces a novel cellular barcoding technique that can be used 
as a powerful tool to assay clonality in the hematopoietic system. This technique 
makes use of retroviral plasmids that are labeled with random sequence tags 
or “barcodes”. Upon retroviral integration, each vector introduces a unique, 
identifiable and heritable mark into the host cell genome, allowing the clonal 
progeny of each cell to be tracked over time. We demonstrate the efficacy of the 
barcoding technique to track clonal dynamics in two distinct cell culture systems 
in vitro and in a hematopoietic transplantation setting in vivo, and emphasizes the 
importance of implementing barcoded vectors in all future clinical gene therapy 
protocols.
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